Clinical Pharmacokinetics in Patients with Spinal Cord Injuries

Clinical Pharmacokinetics

Volumn 17, Issue 2, 1989, Pages 109-129

  Segal, Jack L ^a,b   Brunnemann, Sherry R ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BACLOFEN; CEPHALOSPORIN; DANTROLENE; DIAZEPAM; DOXYCYCLINE; GENTAMICIN; LORAZEPAM; METOCLOPRAMIDE; PARACETAMOL; RANITIDINE; RIBOFLAVIN; THEOPHYLLINE; TOBRAMYCIN;

HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY;

ANIMAL; BIOLOGICAL AVAILABILITY; DRUG THERAPY; HUMAN; PHARMACOKINETICS; SPINAL CORD INJURIES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; TISSUE DISTRIBUTION;

EID: 0024334695     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/00003088-198917020-00004     Document Type: Review

References (69)

1. Absolute and relative bioavailability of oral acetaminophen preparations
2. Aminophylline improves diaphragmatic contractility
3. Body composition in chronic undernutrition
4. La commande nerveuse de la veino-constriction périphérique du début de l’exercice
5. Methylprednisolone and neurological function 1 year after spinal cord injury
6. High density lipoprotein cholesterol concentration in physically active and sedentary spinal cord injured patients
7. Metabolic and endocrine changes in spinal cord injury (four part series)
8. Prediction of creatinine clearance from serum creatinine
9. Paraplegia: problems confronting the anaesthesiologist
10. Glucose intolerance due to insulin resistance in patients with spinal cord injuries
11. Evaluation of a muscle relaxant: dantrolene sodium (dantrium)
12. Effect of traumatic spinal cord transection on human upper gastrointestinal motility and gastric emptying
13. Dantrolene dose response in awake man: implications for management of malignant hyperthermia
14. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia
15. Increasing survival and changing causes of death in myelopathy patients
16. The effect of cervical cord injury on cardiac rhythm and conduction
17. Long-term changes in gross body composition of paraplegic and quadriplegic patients
18. Deficiency within intrinsic prothrombin activator system in patients with acute spinal cord injury
19. Drug absorption in spinal cord injury
20. Ventilatory dysfunction and respiratory rehabilitation in post traumatic quadriplegia
21. An evaluation of antibiotic dosage regimen for urinary tract infection in spinal cord injury patients
22. Simultaneous determination of dantrolene and its metabolite, 5-hydroxydantrolene, in human plasma by high-performance liquid chromatography
23. Extravascular albumin in human tissues
24. Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis
25. Effect of obesity on acetaminophen pharmacokinetics in man
26. Dynamics of doxycycline levels in cases with trauma of the spinal marrow
27. A comparative study of gentamicin pharmacokinetics in spinal cord-injured with incomplete spinal lesion and healthy adults
28. Cardiovascular control in recently injured tetraplegics in spinal shock
29. Clinical manifestations of malfunctioning sympathetic mechanism in tetraplegia
30. Relationship between plasma concentration and effect of dantrolene sodium in man
31. Prediction of creatinine clearance from serum creatinine in spinal cord injury patients
32. The evaluation of creatinine clearance in spinal cord injury patients
33. Pharmacokinetics of ranitidine in quadriplegics
34. Pharmacological modification of gastric emptying: effects of propantheline and metoclopromide on paracetamol absorption
35. Anemia in patients with traumatic spinal cord injury
36. Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy
37. The distribution of proteins between intra- and extravascular spaces in health and disease
38. Defects in regulatory mechanisms of autonomic function in injuries to spinal cord
39. Responses of patients with high spinal transection to high ambient temperatures
40. Body composition of patients with spinal cord injury
41. Comparative pharmacokinetics of tobramycin and gentamicin
42. The aminoglycosides (symposium on antimicrobial therapy)
43. Ventilatory compromise in spinal cord injury — a review
44. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications
45. Decreased theophylline bioavailability and impaired gastric emptying in spinal cord injury
46. The absolute bioavailability of oral theophylline in patients with spinal cord injury
47. Amikacin pharmacokinetics in patients with spinal cord injury
48. Gentamicin bioavailability and single-dose pharmacokinetics in spinal cord injury
49. Impaired absorption of intramuscularly administered gentamicin in spinal cord injury
50. Theophylline disposition in tetraplegic man
51. Pharmacokinetics of gentamicin in patients with spinal cord injury
52. Gentamicin disposition kinetics in humans with spinal cord injury
53. Metoclopramide-induced normalization of impaired gastric emptying in spinal cord injury
54. Theophylline pharmacokinetics in paraplegic subjects
55. Blood flow in muscles of paraplegic patients under various conditions measured by a double isotope technique
56. Gastroduodenal disease in chronic spinal cord injuries
57. Protein C abnormalities in spinal cord injured patients with end-stage renal disease
58. Plasma volume and extracellular fluid volume change associated with 10 days bed recumbency
59. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update on its use in muscle spasticity
60. Circulatory reflexes in tetraplegics during artificial ventilation and general anaesthesia
61. Pharmacological therapy of acute spinal cord injury: studies of high dose methylprednisolone and naloxone